CCL2 and neoplasm: recently demonstrated that by increasing VE-Cadherin expression and normalizing tumor vasculature, CD5-2 enhanced the expression of chemokines involved in CD8+ T cell transcellular migration including CCL2, CXCL10, CXCL11 and CXCL8 (24).